CORT logo

CORT CAPEX

Annual CAPEX

$139.00 K
-$274.00 K-66.34%

December 31, 2023

Summary

Performance

1-Year Change

-66.34%

3-Year Change

-88.77%

5-Year Change

-53.36%

15-Year Change

-66.83%

CORT CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

14.78%
CORT annual capital expenditures is higher than 14.78% of companies in Healthcare sector

High & Low

All-time High

$1.31 M
CORT annual capital expenditures is currently -89.43% below its historical high of $1.31 million

3-Year Low

$139.00 K
CORT annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CORT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 14, 2025
CORT next annual earnings announcement is scheduled for Feb 14, 2025

OtherCORTcash flowmetrics:

Annual FCF

$126.90 M
CORT annual free cash flow is $126.90 million

Annual CFO

$127.04 M
CORT annual cash flow from operations is $127.04 million

Annual CFI

$90.91 M
CORT annual cash flow from investing activities is $90.91 million

Annual CFF

-$148.72 M
CORT annual cash flow from financing activities is -$148.72 million

Quarterly CAPEX

$1.64 M
+$1.22 M+293.03%

September 30, 2024

Summary

Performance

3-Month Change

+293.03%

1-Year Change

-

3-Year Change

+5174.19%

5-Year Change

+5174.19%

CORT Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

60.88%
CORT quarterly capital expenditures is higher than 60.88% of companies in Healthcare sector

High & Low

All-time High

$1.64 M
CORT quarterly capital expenditures is currently at an all-time high

3-Year Low

$0.00
CORT quarterly capital expenditures is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CORT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
CORT next earnings announcement is scheduled for Feb 14, 2025

OtherCORTcash flowmetrics:

Quarterly FCF

$72.19 M
CORT quarterly free cash flow is $72.19 million

Quarterly CFO

$73.83 M
CORT quarterly cash flow from operations is $73.83 million

Quarterly CFI

-$44.04 M
CORT quarterly cash flow from investing activities is -$44.04 million

Quarterly CFF

-$21.09 M
CORT quarterly cash flow from financing activities is -$21.09 million

TTM CAPEX

$2.05 M
+$1.60 M+352.76%

September 30, 2024

Summary

Performance

3-Month Change

+352.76%

1-Year Change

-

3-Year Change

+396.61%

5-Year Change

+396.61%

CORT TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

42.94%
CORT TTM capital expenditures is higher than 42.94% of companies in Healthcare sector

High & Low

All-time High

$2.05 M
CORT TTM capital expenditures is currently at an all-time high

3-Year Low

$139.00 K
CORT TTM capital expenditures is currently +1375.54% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CORT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
CORT next earnings announcement is scheduled for Feb 14, 2025

OtherCORTcash flowmetrics:

TTM FCF

$142.60 M
CORT TTM free cash flow is $142.60 million

TTM CFO

$144.65 M
CORT TTM cash flow from operations is $144.65 million

TTM CFI

-$96.15 M
CORT TTM cash flow from investing activities is -$96.15 million

TTM CFF

-$23.02 M
CORT TTM cash flow from financing activities is -$23.02 million

CORT CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-66.3%--
3 y3 years-88.8%+5174.2%+396.6%
5 y5 years-53.4%+5174.2%+396.6%

CORT CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-70.4%at lowat high-100.0%at high+1375.5%
5 y5-year-88.8%at lowat high-100.0%at high+1375.5%
alltimeall time-89.4%+1885.7%at high+9717.6%at high>+9999.0%

Corcept Therapeutics Incorporated CAPEX History

DateAnnualQuarterlyTTM
Sep 2024
-
$1.64 M(+293.0%)
$2.05 M(+352.8%)
Jun 2024
-
$416.00 K(>+9900.0%)
$453.00 K(+225.9%)
Dec 2023
$139.00 K(-66.3%)
$0.00(-100.0%)
$139.00 K(-18.2%)
Sep 2023
-
$37.00 K(-63.7%)
$170.00 K(-64.9%)
Jun 2023
-
$102.00 K(+229.0%)
$484.00 K(+17.2%)
Dec 2022
$413.00 K(-11.9%)
$31.00 K(-91.2%)
$413.00 K(-7.6%)
Sep 2022
-
$351.00 K(+1747.4%)
$447.00 K(+75.3%)
Jun 2022
-
$19.00 K(+58.3%)
$255.00 K(-28.2%)
Mar 2022
-
$12.00 K(-81.5%)
$355.00 K(-24.3%)
Dec 2021
$469.00 K(-62.1%)
$65.00 K(-59.1%)
$469.00 K(-43.8%)
Sep 2021
-
$159.00 K(+33.6%)
$835.00 K(-40.1%)
Jun 2021
-
$119.00 K(-5.6%)
$1.39 M(+5.4%)
Mar 2021
-
$126.00 K(-70.8%)
$1.32 M(+6.8%)
Dec 2020
$1.24 M(+13.8%)
$431.00 K(-40.0%)
$1.24 M(+31.4%)
Sep 2020
-
$718.00 K(+1427.7%)
$942.00 K(+84.7%)
Jun 2020
-
$47.00 K(+11.9%)
$510.00 K(-41.6%)
Mar 2020
-
$42.00 K(-68.9%)
$873.00 K(-19.8%)
Dec 2019
$1.09 M(+265.1%)
$135.00 K(-52.8%)
$1.09 M(+2.1%)
Sep 2019
-
$286.00 K(-30.2%)
$1.07 M(+29.2%)
Jun 2019
-
$410.00 K(+59.5%)
$825.00 K(+72.6%)
Mar 2019
-
$257.00 K(+127.4%)
$478.00 K(+60.4%)
Dec 2018
$298.00 K(-28.9%)
$113.00 K(+151.1%)
$298.00 K(+39.3%)
Sep 2018
-
$45.00 K(-28.6%)
$214.00 K(-14.7%)
Jun 2018
-
$63.00 K(-18.2%)
$251.00 K(-35.0%)
Mar 2018
-
$77.00 K(+165.5%)
$386.00 K(-7.9%)
Dec 2017
$419.00 K
$29.00 K(-64.6%)
$419.00 K(-9.9%)
DateAnnualQuarterlyTTM
Sep 2017
-
$82.00 K(-58.6%)
$465.00 K(-1.7%)
Jun 2017
-
$198.00 K(+80.0%)
$473.00 K(+67.7%)
Mar 2017
-
$110.00 K(+46.7%)
$282.00 K(+45.4%)
Dec 2016
$194.00 K(+1041.2%)
$75.00 K(-16.7%)
$194.00 K(+90.2%)
Sep 2016
-
$90.00 K(+1185.7%)
$102.00 K(+750.0%)
Jun 2016
-
$7000.00(-68.2%)
$12.00 K(+140.0%)
Mar 2016
-
$22.00 K(-229.4%)
$5000.00(-70.6%)
Dec 2015
$17.00 K(-90.2%)
-$17.00 K(<-9900.0%)
$17.00 K(-50.0%)
Sep 2015
-
$0.00(0.0%)
$34.00 K(-32.0%)
Jun 2015
-
$0.00(-100.0%)
$50.00 K(-49.0%)
Mar 2015
-
$34.00 K(>+9900.0%)
$98.00 K(-43.7%)
Dec 2014
$174.00 K(+37.0%)
$0.00(-100.0%)
$174.00 K(-18.7%)
Sep 2014
-
$16.00 K(-66.7%)
$214.00 K(-18.6%)
Jun 2014
-
$48.00 K(-56.4%)
$263.00 K(+20.1%)
Mar 2014
-
$110.00 K(+175.0%)
$219.00 K(+72.4%)
Dec 2013
$127.00 K(-15.9%)
$40.00 K(-38.5%)
$127.00 K(-12.4%)
Sep 2013
-
$65.00 K(+1525.0%)
$145.00 K(+9.8%)
Jun 2013
-
$4000.00(-77.8%)
$132.00 K(-18.5%)
Mar 2013
-
$18.00 K(-69.0%)
$162.00 K(+7.3%)
Dec 2012
$151.00 K(+504.0%)
$58.00 K(+11.5%)
$151.00 K(+62.4%)
Sep 2012
-
$52.00 K(+52.9%)
$93.00 K(+126.8%)
Jun 2012
-
$34.00 K(+385.7%)
$41.00 K(+485.7%)
Mar 2012
-
$7000.00
$7000.00
Dec 2011
$25.00 K(+257.1%)
-
-
Dec 2008
$7000.00(-99.5%)
-
-
Dec 2006
$1.31 M
-
-

FAQ

  • What is Corcept Therapeutics Incorporated annual capital expenditures?
  • What is the all time high annual CAPEX for Corcept Therapeutics Incorporated?
  • What is Corcept Therapeutics Incorporated annual CAPEX year-on-year change?
  • What is Corcept Therapeutics Incorporated quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Corcept Therapeutics Incorporated?
  • What is Corcept Therapeutics Incorporated TTM capital expenditures?
  • What is the all time high TTM CAPEX for Corcept Therapeutics Incorporated?

What is Corcept Therapeutics Incorporated annual capital expenditures?

The current annual CAPEX of CORT is $139.00 K

What is the all time high annual CAPEX for Corcept Therapeutics Incorporated?

Corcept Therapeutics Incorporated all-time high annual capital expenditures is $1.31 M

What is Corcept Therapeutics Incorporated annual CAPEX year-on-year change?

Over the past year, CORT annual capital expenditures has changed by -$274.00 K (-66.34%)

What is Corcept Therapeutics Incorporated quarterly capital expenditures?

The current quarterly CAPEX of CORT is $1.64 M

What is the all time high quarterly CAPEX for Corcept Therapeutics Incorporated?

Corcept Therapeutics Incorporated all-time high quarterly capital expenditures is $1.64 M

What is Corcept Therapeutics Incorporated TTM capital expenditures?

The current TTM CAPEX of CORT is $2.05 M

What is the all time high TTM CAPEX for Corcept Therapeutics Incorporated?

Corcept Therapeutics Incorporated all-time high TTM capital expenditures is $2.05 M